Skip to content

Clinical trials

Completed Macular Degeneration trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: Switzerland Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20064
20071
20082
20101
20112
20131
20155
20171
20181
20191
20202
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern5
Novartis Pharmaceuticals5
Novartis4
Allergan2
Bayer2
University Hospital, Basel, Switzerland2
Vista Klinik2
Association for Innovation and Biomedical Research on Light and Image1
Dr. med. Katja Hatz1
Institute of Molecular and Clinical Ophthalmology Basel1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration29
Choroidal Neovascularization10
Geographic Atrophy5
Vision Disorders4
Eye Diseases3
Retinal Diseases3
Wet Macular Degeneration3
Retinal Degeneration2
Retinal Vein Occlusion2
Atrophy1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.